Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\RNA (MicroRNA).php on line 2
RNA (MicroRNA)
LE WE PMID CA
RNA (MicroRNA)1781RNA (MicroRNA)

Acidosis (metabolic)

Aids

Angiogenesis

Antagomir

Antibiotics (BASKET)

Antisense

Antiviral agents

Aptamer

Argonaute

Arthritis (rheumatoid)

beta cell (Pancreas)

Blood vessels (Physiology)

Cajal body

Calreticulin

Cell cylce (BASKET)

Cell stress (BASKET)

Circadian clock

CMV

CNS (Development)

CNS (Neoplasia Neuroblastoma)

Colon and rectum (Neoplasia)

CoREST

CRIPSR

Data base (Medicine Biology Pharmacology)

DNA (Repair and Toxicology)

Dnd1

Embryology (BASKET)

Endothelium

Epigenetics

Epithelio mesenchymal transition

FMR1 FMRP

FXR1P

FXR2P

Gene expression

Gene transfer

Genetic instability

Genetics (GWAS Genome wide association study)

Genetics (Transposon)

Hepatitis C

Herpes simplex virus

Heterochromatin

High throughput screening

HLA and MHC

Host pathogen interaction

Hox

Human genetics (BASKET)

HuR

Hypometabolism

Kidney (Compensatory hypertrophy)

LET7

Leukemia (BASKET)

Leukemia (chronic lymphatic)

LINE1

Lung and bronchial system (Neoplasia NSCLC)

Lung and bronchial system (Neoplasia)

Microarray (Gene expression analysis)

MiRNA 155

Morphogenesis (Development)

Muscle (Neoplasia Rhabdomyosarcoma)

Muscle (Physiology)

Myc

Nanomedicine

Neoplasia (Carcinogenesis)

Neoplasia (Fusion oncogenes)

Neoplasia (Invasion and metastasis)

Neoplasia (Oncolytic virus)

Neoplasia (Tumor biology and immunology)

Neoplasia (Tumor markers)

Neurodegeneration

NFKB

Notch

Oocyte (BASKET)

P53

Pancreas (Neoplasia)

PCR

Pharmacogenomics

Plants (BASKET)

Prostate (Neoplasia)

Proteasome (BASKET)

REST

RNA (Binding proteins)

RNA (Decay)

RNA (endo siRNA)

RNA (MicroRNA)

RNA (non coding)

RNA (nRNA BASKET)

RNA (piRNA)

RNA (RNase III)

RNA (shRNA)

Schistosoma

Sequencing (Nucleic acids)

SMAD

Stem cell (BASKET)

Stem cell (Embryonal)

Stem cell (Induced pluripotential)

Synthetic biology

Systemic lupus erythematosus

TGF beta

Torpor

Tularemia

Virus (BASKET)

Virus (RNA virus)

Wnt beta Catenin TCF

ZEB1

ZEB2

2009  
1
The RNA-induced silencing complex: a versatile gene-silencing machine.
[19342379] J Biol Chem 284(27): 17897-901 (2009)
2005  
2
Nonsense-mediated mRNA decay in mammals.
[15860725] J Cell Sci 118(Pt 9): 1773-6 (2005)
2003  
3
RNA interference in functional genomics and medicine.
[12808314] J Korean Med Sci 18(3): 309-18 (2003)
2008  
4
2006  
5
2010  
6
MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration.
[20606686] J Cereb Blood Flow Metab 30(9): 1564-76 (2010)
2008  
7
Role of microRNAs in vascular diseases, inflammation, and angiogenesis.
[18550634] Cardiovasc Res 79(4): 581-8 (2008)
2008  
8
MicroRNA: basic mechanisms and transcriptional regulatory networks for cell fate determination.
[18539629] Cardiovasc Res 79(4): 553-61 (2008)
2008  
9
MicroRNAs: novel regulators in cardiac development and disease.
[18511432] Cardiovasc Res 79(4): 562-70 (2008)
2003  
10
RNA interference in biology and medicine.
[14657420] Pharmacol Rev 55(4): 629-48 (2003)
2010  
11
MicroRNAs: a novel class of potential therapeutic targets for cardiovascular diseases.
[19966833] Acta Pharmacol Sin 31(1): 1-9 (2010)
2006  
12
Targeting leukemic fusion proteins with small interfering RNAs: recent advances and therapeutic potentials.
[16490161] Acta Pharmacol Sin 27(3): 273-81 (2006)
2008  
13
Inhalable siRNA: potential as a therapeutic agent in the lungs.
[18491918] Mol Pharm 5(4): 559-66 (2008)
2008  
14
RNA interference: a multifaceted innate antiviral defense.
[18241347] Retrovirology 5(-): 17 (2008)
2003  
15
RNA interference: biology, mechanism, and applications.
[14665679] Microbiol Mol Biol Rev 67(4): 657-85 (2003)
1995  
16
mRNA stability in mammalian cells.
[7565413] Microbiol Rev 59(3): 423-50 (1995)
1984  
17
Double-stranded ribonucleic acid killer systems in yeasts.
[6377033] Microbiol Rev 48(2): 125-56 (1984)
2009  
18
Oncoviruses and Pathogenic MicroRNAs in Humans.
[19920887] Open Virol J 3(-): 37-51 (2009)
2006  
19
2007  
20
Host-virus genome interactions: macro roles for microRNAs.
[17944962] Cell Microbiol 9(12): 2784-94 (2007)
2006  
21
Virus-encoded microRNAs: future therapeutic targets?
[17257494] Cell Mol Immunol 3(6): 411-9 (2006)
2007  
22
Dicing with viruses: microRNAs as antiviral factors.
[17663977] Immunity 27(1): 1-3 (2007)
2004  
23
2007  
24
Immunological research using RNA interference technology.
[17428313] Immunology 121(3): 295-307 (2007)
2010  
25
RNA silencing in the antiviral innate immune defence--role of DEAD-box RNA helicases.
[20415780] Scand J Immunol 71(3): 146-58 (2010)
2009  
26
The promises and pitfalls of RNA-interference-based therapeutics.
[19158789] Nature 457(7228): 426-33 (2009)
2003  
27
RNA interference and its role in the regulation of eucaryotic gene expression.
[12673363] Acta Biochim Pol 50(1): 217-29 (2003)
2007  
28
Prediction and validation of microRNA targets in animal genomes.
[17954966] J Biosci 32(6): 1049-52 (2007)
2007  
29
High-content siRNA screening.
[17372651] Mol Biosyst 3(4): 232-40 (2007)
2008  
30
The evolution and functional diversification of animal microRNA genes.
[18711447] Cell Res 18(10): 985-96 (2008)
2007  
31
Beginning to understand microRNA function.
[17694094] Cell Res 17(8): 661-3 (2007)
2007  
32
Biochemical mechanisms of the RNA-induced silencing complex.
[17310219] Cell Res 17(3): 187-94 (2007)
2004  
33
RNAi, a new therapeutic strategy against viral infection.
[15625012] Cell Res 14(6): 460-6 (2004)
2001  
34
Gene silencing: double-stranded RNA mediated mRNA degradation and gene inactivation.
[11642402] Cell Res 11(3): 181-6 (2001)
2010  
35
How do miRNAs mediate translational repression?
[20459656] Silence 1(1): 11 (2010)
2010  
36
Aptamer-targeted cell-specific RNA interference.
[20226078] Silence 1(1): 4 (2010)
2009  
37
microRNAs and genetic diseases.
[19889204] Pathogenetics 2(1): 7 (2009)
2009  
38
The GW182 protein family in animal cells: new insights into domains required for miRNA-mediated gene silencing.
[19535464] RNA 15(8): 1433-42 (2009)
2007  
39
Unique folding of precursor microRNAs: quantitative evidence and implications for de novo identification.
[17194722] RNA 13(2): 170-87 (2007)
2005  
40
MicroRNA function: multiple mechanisms for a tiny RNA?
[16314451] RNA 11(12): 1753-61 (2005)
2003  
41
A uniform system for microRNA annotation.
[12592000] RNA 9(3): 277-9 (2003)
2007  
42
Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting.
[17329355] RNA 13(4): 431-56 (2007)
1995  
43
When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells.
[7489507] RNA 1(5): 453-65 (1995)
2010  
44
Unified translation repression mechanism for microRNAs and upstream AUGs.
[20205738] BMC Genomics 11(-): 155 (2010)
2009  
45
Epigenetic Control of MicroRNA Expression and Aging.
[19881911] Curr Genomics 10(3): 184-93 (2009)
2004  
46
Technique review: how to use RNA interference.
[15163361] Brief Funct Genomic Proteomic 3(1): 68-83 (2004)
2006  
47
RNAi: a defensive RNA-silencing against viruses and transposable elements.
[16369574] Heredity 96(2): 195-202 (2006)
2009  
48
The evolution of RNAi as a defence against viruses and transposable elements.
[18926973] Philos Trans R Soc Lond B Biol Sci 364(1513): 99-115 (2009)
2006  
49
The silence RNA keeps: cis mechanisms of RNA mediated epigenetic silencing in mammals.
[16553309] Philos Trans R Soc Lond B Biol Sci 361(1465): 67-79 (2006)
2009  
50
The role of microRNAs in synaptic development and function.
[19335998] BMB Rep 42(3): 131-5 (2009)
2009  
51
Emerging roles of RNA and RNA-binding protein network in cancer cells.
[19335997] BMB Rep 42(3): 125-30 (2009)
2005  
52
RNA interference: past, present and future.
[15580776] Curr Issues Mol Biol 7(1): 1-6 (2005)
2009  
53
The fascinating world of RNA interference.
[19173032] Int J Biol Sci 5(2): 97-117 (2009)
2010  
54
Advances in synthetic siRNA delivery.
[20515610] Discov Med 9(48): 418-30 (2010)
2006  
55
The RNA interference pathway: a new target for autoimmunity.
[16805905] Arthritis Res Ther 8(4): 110 (2006)
2009  
56
MicroRNAs and their role in progressive kidney diseases.
[19581401] Clin J Am Soc Nephrol 4(7): 1255-66 (2009)
2008  
57
Review article: RNA interference--potential therapeutic applications for the gastroenterologist.
[18248657] Aliment Pharmacol Ther 27(9): 715-23 (2008)
2008  
58
MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management.
[18223209] Clin Cancer Res 14(2): 360-5 (2008)
2006  
59
Therapeutic potential of RNA interference against cancer.
[16863503] Cancer Sci 97(8): 689-96 (2006)
2007  
60
The guardian's little helper: microRNAs in the p53 tumor suppressor network.
[18056431] Cancer Res 67(23): 11099-101 (2007)
2007  
61
MicroRNAs in biological processes and carcinogenesis.
[17028302] Carcinogenesis 28(1): 2-12 (2007)
2009  
62
MicroRNAs in colorectal cancer: translation of molecular biology into clinical application.
[19912656] Mol Cancer 8(-): 102 (2009)
2007  
63
OncomiRs: the discovery and progress of microRNAs in cancers.
[17894887] Mol Cancer 6(-): 60 (2007)
2007  
64
Noncoding RNAs and RNA editing in brain development, functional diversification, and neurological disease.
[17615389] Physiol Rev 87(3): 799-823 (2007)
2008  
65
Everything you wanted to know about small RNA but were afraid to ask.
[18427554] Lab Invest 88(6): 569-78 (2008)
2009  
66
Common themes in siRNA-mediated epigenetic silencing pathways.
[19412884] Int J Dev Biol 53(2-3): 245-57 (2009)
2009  
67
The function of non-coding RNAs in genomic imprinting.
[19429783] Development 136(11): 1771-83 (2009)
2008  
68
The growing catalog of small RNAs and their association with distinct Argonaute/Piwi family members.
[18287206] Development 135(7): 1201-14 (2008)
2008  
69
Biogenesis and germline functions of piRNAs.
[18032451] Development 135(1): 3-9 (2008)
2007  
70
The regulation of genes and genomes by small RNAs.
[17409118] Development 134(9): 1635-41 (2007)
2005  
71
MicroRNA functions in animal development and human disease.
[16224045] Development 132(21): 4653-62 (2005)
2005  
72
microPrimer: the biogenesis and function of microRNA.
[16224044] Development 132(21): 4645-52 (2005)
2007  
73
The exosome and RNA quality control in the nucleus.
[17603538] EMBO Rep 8(7): 651-7 (2007)
2006  
74
The exosome and the proteasome: nano-compartments for degradation.
[16713559] Cell 125(4): 651-4 (2006)
1999  
75
The exosome: a proteasome for RNA?
[10571176] Cell 99(4): 347-50 (1999)
1998  
76
The exosome: a versatile RNA processing machine.
[9583939] Curr Biol 8(7): R238-40 (1998)
2009  
77
2007  
78
Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies.
[17717148] Am J Pathol 171(4): 1079-88 (2007)
2007  
79
MicroRNAs in tumorigenesis: a primer.
[17724137] Am J Pathol 171(3): 728-38 (2007)
2007  
80
Regulation of microRNA by antagomirs: a new class of pharmacological antagonists for the specific regulation of gene function?
[16917074] Am J Respir Cell Mol Biol 36(1): 8-12 (2007)
2005  
81
Therapeutic potential of small interfering RNA for central nervous system diseases.
[16344338] Arch Neurol 62(12): 1810-3 (2005)
2005  
82
Exploring the functions of RNA interference pathway proteins: some functions are more RISCy than others?
[15845026] Biochem J 387(Pt 3): 561-71 (2005)
2004  
83
Optimizing RNA interference for application in mammalian cells.
[15056071] Biochem J 380(Pt 3): 593-603 (2004)
2006  
84
MicroRNAs: regulators of gene expression and cell differentiation.
[16882713] Blood 108(12): 3646-53 (2006)
2005  
85
RNA interference in biology and disease.
[15827131] Blood 106(3): 787-94 (2005)
2009  
86
Small RNAs as guardians of the genome.
[19239887] Cell 136(4): 656-68 (2009)
2009  
87
Regulation of MicroRNA Biogenesis: A miRiad of mechanisms.
[19664273] Cell Commun Signal 7(-): 18 (2009)
2008  
88
The long and short of inverted repeat genes in animals: microRNAs, mirtrons and hairpin RNAs.
[18769156] Cell Cycle 7(18): 2840-5 (2008)
2006  
89
Immense promises for tiny molecules: uncovering miRNA functions.
[16775415] Cell Cycle 5(13): 1415-21 (2006)
2005  
90
MicroRNAs: critical regulators of development, cellular physiology and malignancy.
[16096373] Cell Cycle 4(9): 1179-84 (2005)
2005  
91
siRNA induced transcriptional gene silencing in mammalian cells.
[15684610] Cell Cycle 4(3): 442-8 (2005)
2008  
92
From sequence to function: using RNAi to elucidate mechanisms of human disease.
[18202701] Cell Death Differ 15(5): 809-19 (2008)
2008  
93
P bodies, stress granules, and viral life cycles.
[18407064] Cell Host Microbe 3(4): 206-12 (2008)
2008  
94
Toward microRNA-based therapeutics for heart disease: the sense in antisense.
[18948630] Circ Res 103(9): 919-28 (2008)
2007  
95
Emerging role of microRNAs in cardiovascular biology.
[18063818] Circ Res 101(12): 1225-36 (2007)
2009  
96
MicroRNAs: regulating a change of heart.
[19398677] Circulation 119(16): 2217-24 (2009)
2006  
97
Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease.
[16757948] Eur J Hum Genet 14(10): 1074-81 (2006)
2005  
98
2009  
99
The role of RNAi and microRNAs in animal virus replication and antiviral immunity.
[19451215] Genes Dev 23(10): 1151-64 (2009)
2007  
100
MicroRNAs repress translation of m7Gppp-capped target mRNAs in vitro by inhibiting initiation and promoting deadenylation.
[17699746] Genes Dev 21(16): 1975-82 (2007)
2007  
101
piRNAs--the ancient hunters of genome invaders.
[17639076] Genes Dev 21(14): 1707-13 (2007)
2007  
102
Eukaryotic regulatory RNAs: an answer to the 'genome complexity' conundrum.
[17210785] Genes Dev 21(1): 11-42 (2007)
2006  
103
Small RNAs just got bigger: Piwi-interacting RNAs (piRNAs) in mammalian testes.
[16882976] Genes Dev 20(15): 1993-7 (2006)
2006  
104
Control of translation and mRNA degradation by miRNAs and siRNAs.
[16510870] Genes Dev 20(5): 515-24 (2006)
2005  
105
Perspective: machines for RNAi.
[15741316] Genes Dev 19(5): 517-29 (2005)
2002  
106
The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis.
[12414724] Genes Dev 16(21): 2733-42 (2002)
2002  
107
Why do miRNAs live in the miRNP?
[12000786] Genes Dev 16(9): 1025-31 (2002)
2007  
108
Applications of high-throughput RNA interference screens to problems in cell and developmental biology.
[17244760] Genetics 175(1): 7-16 (2007)
2008  
109
The Argonaute protein family.
[18304383] Genome Biol 9(2): 210 (2008)
2004  
110
RNAi for research and therapy.
[15345042] Genome Biol 5(9): 342 (2004)
2004  
111
Predicting and validating microRNA targets.
[15345038] Genome Biol 5(9): 115 (2004)
2004  
112
Nonsense-mediated mRNA decay: from vacuum cleaner to Swiss army knife.
[15059251] Genome Biol 5(4): 218 (2004)
2003  
113
Towards a complete description of the microRNA complement of animal genomes.
[12952528] Genome Biol 4(9): 228 (2003)
2002  
114
Beyond the proteome: non-coding regulatory RNAs.
[12049667] Genome Biol 3(5): reviews0005 (2002)
2002  
115
Integration of splicing, transport and translation to achieve mRNA quality control by the nonsense-mediated decay pathway.
[11897029] Genome Biol 3(3): REVIEWS1006 (2002)
2007  
116
2004  
117
RNA interference: from model organisms towards therapy for neural and neuromuscular disorders.
[15358735] Hum Mol Genet 13 Spec No 2(-): R275-88 (2004)
1999  
118
Nonsense-mediated mRNA decay in health and disease.
[10469842] Hum Mol Genet 8(10): 1893-900 (1999)
2008  
119
Piecing together the mosaic of early mammalian development through microRNAs.
[18272516] J Biol Chem 283(15): 9505-8 (2008)
2007  
120
RISCy business: MicroRNAs, pathogenesis, and viruses.
[17627941] J Biol Chem 282(37): 26641-5 (2007)
2008  
121
Regulation of microRNA processing in development, differentiation and cancer.
[18752632] J Cell Mol Med 12(5B): 1811-9 (2008)
2007  
122
Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?
[18060021] J Clin Invest 117(12): 3633-41 (2007)
2007  
123
Nonviral delivery of synthetic siRNAs in vivo.
[18060020] J Clin Invest 117(12): 3623-32 (2007)
2007  
124
Chemical modification: the key to clinical application of RNA interference?
[18060019] J Clin Invest 117(12): 3615-22 (2007)
2007  
125
On future's doorstep: RNA interference and the pharmacopeia of tomorrow.
[18060018] J Clin Invest 117(12): 3612-4 (2007)
2007  
126
MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets.
[17786230] J Clin Invest 117(9): 2369-76 (2007)
2007  
127
Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications.
[17671640] J Clin Invest 117(8): 2059-66 (2007)
2002  
128
Killing the messenger: new insights into nonsense-mediated mRNA decay.
[11781342] J Clin Invest 109(1): 3-6 (2002)
2004  
129
RNA interference and the use of small interfering RNA to study gene function in mammalian systems.
[15591019] J Mol Endocrinol 33(3): 545-57 (2004)
2005  
130
RNA interference and nonviral targeted gene therapy of experimental brain cancer.
[15717065] NeuroRx 2(1): 139-50 (2005)
2009  
131
Profiling of mismatch discrimination in RNAi enabled rational design of allele-specific siRNAs.
[19815667] Nucleic Acids Res 37(22): 7560-9 (2009)
2009  
132
Current tools for the identification of miRNA genes and their targets.
[19295136] Nucleic Acids Res 37(8): 2419-33 (2009)
2009  
133
Cellular versus viral microRNAs in host-virus interaction.
[19095692] Nucleic Acids Res 37(4): 1035-48 (2009)
2009  
134
miR2Disease: a manually curated database for microRNA deregulation in human disease.
[18927107] Nucleic Acids Res 37(Database issue): D98-104 (2009)
2008  
135
Effect of asymmetric terminal structures of short RNA duplexes on the RNA interference activity and strand selection.
[18782830] Nucleic Acids Res 36(18): 5812-21 (2008)
2008  
136
MicroRNomics: a newly emerging approach for disease biology.
[18303086] Physiol Genomics 33(2): 139-47 (2008)
2009  
137
The genetic signatures of noncoding RNAs.
[19390609] PLoS Genet 5(4): e1000459 (2009)
2008  
138
miRNA, siRNA, piRNA: Knowns of the unknown.
[19182524] RNA Biol 5(4): 181-8 (2008)
2006  
139
microRNA-mediated silencing inside P-bodies.
[17179742] RNA Biol 3(3): 97-100 (2006)
2005  
140
Selecting effective siRNA target sequences for mammalian genes.
[17132936] RNA Biol 2(1): 21-7 (2005)
2004  
141
RNA interference: from biology to drugs and therapeutics.
[17179744] RNA Biol 1(2): 118-21 (2004)
2007  
142
The Piwi-piRNA pathway provides an adaptive defense in the transposon arms race.
[17975059] Science 318(5851): 761-4 (2007)
2007  
143
2008  
144
miRNAs: effectors of environmental influences on gene expression and disease.
[18281715] Toxicol Sci 103(2): 228-40 (2008)
2009  
145
MicroRNA signatures in liver diseases.
[19360909] World J Gastroenterol 15(14): 1665-72 (2009)
2007  
146
RNA interference and antiviral therapy.
[17876887] World J Gastroenterol 13(39): 5169-79 (2007)
2008  
147
Getting to the root of miRNA-mediated gene silencing.
[18191211] Cell 132(1): 9-14 (2008)
2007  
148
Noncoding RNAs and gene silencing.
[17320512] Cell 128(4): 763-76 (2007)
2006  
149
Rethinking the microprocessor.
[16751089] Cell 125(5): 827-9 (2006)
2005  
150
RNAi: the nuts and bolts of the RISC machine.
[16009129] Cell 122(1): 17-20 (2005)
2005  
151
The role of the RNAi machinery in heterochromatin formation.
[16009128] Cell 122(1): 13-6 (2005)
2005  
152
Silence from within: endogenous siRNAs and miRNAs.
[16009127] Cell 122(1): 9-12 (2005)
2005  
153
RNA interference libraries prove their worth in hunt for tumor suppressor genes.
[15960967] Cell 121(6): 813-5 (2005)
2004  
154
Dicers at RISC; the mechanism of RNAi.
[15066275] Cell 117(1): 1-3 (2004)
2004  
155
MicroRNAs: genomics, biogenesis, mechanism, and function.
[14744438] Cell 116(2): 281-97 (2004)
2001  
156
microRNAs: tiny regulators with great potential.
[11779458] Cell 107(7): 823-6 (2001)
2001  
157
A short primer on RNAi: RNA-directed RNA polymerase acts as a key catalyst.
[11719182] Cell 107(4): 415-8 (2001)
1999  
158
A perfect message: RNA surveillance and nonsense-mediated decay.
[10025395] Cell 96(3): 307-10 (1999)
2006  
159
MicroRNAs: a new class of regulatory genes affecting metabolism.
[16814728] Cell Metab 4(1): 9-12 (2006)
2005  
160
miRNAs: whys and wherefores of miRNA-mediated regulation.
[15964265] Curr Biol 15(12): R458-60 (2005)
2006  
161
The diverse functions of microRNAs in animal development and disease.
[17011485] Dev Cell 11(4): 441-50 (2006)
2007  
162
mRNA quality control: an ancient machinery recognizes and degrades mRNAs with nonsense codons.
[17531985] FEBS Lett 581(15): 2845-53 (2007)
2005  
163
Non-cell autonomous RNA silencing.
[16242131] FEBS Lett 579(26): 5858-71 (2005)
2005  
164
Dicing and slicing: the core machinery of the RNA interference pathway.
[16214139] FEBS Lett 579(26): 5822-9 (2005)
2005  
165
Prediction and validation of microRNAs and their targets.
[16214134] FEBS Lett 579(26): 5904-10 (2005)
2005  
166
Small RNA asymmetry in RNAi: function in RISC assembly and gene regulation.
[16199039] FEBS Lett 579(26): 5850-7 (2005)
2005  
167
Approaches for chemically synthesized siRNA and vector-mediated RNAi.
[16199038] FEBS Lett 579(26): 5974-81 (2005)
2005  
168
Suppressors of RNA silencing encoded by plant viruses and their role in viral infections.
[16162340] FEBS Lett 579(26): 5958-64 (2005)
2005  
169
Identification and characterization of small RNAs involved in RNA silencing.
[16153643] FEBS Lett 579(26): 5830-40 (2005)
2005  
170
Genome-wide application of RNAi to the discovery of potential drug targets.
[16153642] FEBS Lett 579(26): 5988-95 (2005)
2005  
171
The therapeutic potential of RNA interference.
[16115631] FEBS Lett 579(26): 5996-6007 (2005)
2005  
172
MicroRNA function in animal development.
[16111679] FEBS Lett 579(26): 5911-22 (2005)
2008  
173
MicroRNA expression profiling: a molecular tool for defining the phenotype of hepatocellular tumors.
[18506877] Hepatology 47(6): 1807-9 (2008)
2008  
174
Let me count the ways: mechanisms of gene regulation by miRNAs and siRNAs.
[18206964] Mol Cell 29(1): 1-7 (2008)
2007  
175
Argonaute proteins: mediators of RNA silencing.
[17560368] Mol Cell 26(5): 611-23 (2007)
2007  
176
The coming of age for Piwi proteins.
[17560367] Mol Cell 26(5): 603-9 (2007)
2007  
177
P bodies and the control of mRNA translation and degradation.
[17349952] Mol Cell 25(5): 635-46 (2007)
2007  
178
Ratcheting mRNA out of the nucleus.
[17289581] Mol Cell 25(3): 327-30 (2007)
2005  
179
Defining and assaying RNAi in mammalian cells.
[15629712] Mol Cell 17(1): 1-10 (2005)
2004  
180
Transcription and processing of human microRNA precursors.
[15610730] Mol Cell 16(6): 861-5 (2004)
2002  
181
The long and short of siRNAs.
[12408811] Mol Cell 10(3): 435-7 (2002)
2005  
182
Structure and function of argonaute proteins.
[16216572] Structure 13(10): 1403-8 (2005)
2005  
183
Systematic search for natural antisense transcripts in eukaryotes (review).
[15647831] Int J Mol Med 15(2): 197-203 (2005)
2002  
184
RNA-mediated gene regulation system: now and the future (Review).
[12239579] Int J Mol Med 10(4): 355-65 (2002)
2010  
185
Regulation of cytokines by small RNAs during skin inflammation.
[20594301] J Biomed Sci 17(-): 53 (2010)
2007  
186
The PNPase, exosome and RNA helicases as the building components of evolutionarily-conserved RNA degradation machines.
[17514363] J Biomed Sci 14(4): 523-32 (2007)
2007  
187
Immunotherapeutic strategies employing RNA interference technology for the control of cancers.
[17103251] J Biomed Sci 14(1): 15-29 (2007)
2006  
188
Current perspectives in intronic micro RNAs (miRNAs).
[16228283] J Biomed Sci 13(1): 5-15 (2006)
2003  
189
Inhibition of virus replication by RNA interference.
[14576463] J Biomed Sci 10(6 Pt 1): 607-16 (2003)
2005  
190
2010  
191
2010  
192
Delivery of siRNA therapeutics: barriers and carriers.
[20544328] AAPS J 12(4): 492-503 (2010)
2010  
193
Small molecule modifiers of the microRNA and RNA interference pathway.
[19937410] AAPS J 12(1): 51-60 (2010)
2009  
194
Therapeutic microRNA strategies in human cancer.
[19876744] AAPS J 11(4): 747-57 (2009)
2009  
195
MicroRNA regulation of cancer stem cells and therapeutic implications.
[19842044] AAPS J 11(4): 682-92 (2009)
2010  
196
Engineering RNA for targeted siRNA delivery and medical application.
[20230868] Adv Drug Deliv Rev 62(6): 650-66 (2010)
2007  
197
RNAi therapeutics: principles, prospects and challenges.
[17449137] Adv Drug Deliv Rev 59(2-3): 75-86 (2007)
2008  
198
Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides.
[18155315] Adv Drug Deliv Rev 60(4-5): 530-6 (2008)
2011  
199
Eating less suppresses microRNA assassins in the brain.
[21389350] Aging (Albany NY) 3(3): 179-80 (2011)
2009  
200
Therapeutic regulation of gene expression in the inner ear using RNA interference.
[19494570] Adv Otorhinolaryngol 66(-): 13-36 (2009)
2008  
201
Importance of microRNAs in skin morphogenesis and diseases.
[18853072] Acta Dermatovenerol Alp Panonica Adriat 17(3): 95-102 (2008)
2011  
202
Tumor-targeted RNA-interference: functional non-viral nanovectors.
[21572539] Am J Cancer Res 1(1): 25-42 (2011)
2004  
203
siRNAs: mechanism of RNA interference, in vivo and potential clinical applications.
[15539939] Cancer Biol Ther 3(11): 1069-74 (2004)
2003  
204
Stable RNA interference (RNAi) in mammalian cells.
[12750566] Cancer Biol Ther 2(2): 211-2 (2003)
2010  
205
MicroRNAs as immune regulators: implications for transplantation.
[20199506] Am J Transplant 10(4): 713-9 (2010)
2008  
206
Multiplexed detection methods for profiling microRNA expression in biological samples.
[17994653] Angew Chem Int Ed Engl 47(4): 644-52 (2008)
2010  
207
Small RNAs - secrets and surprises of the genome.
[20409269] Plant J 61(6): 941-58 (2010)
2011  
208
MicroRNA-mediated establishment of transcription factor gradients controlling developmental phase transitions.
[21543901] Plant Signal Behav 6(6): 873-7 (2011)
2011  
209
Barley stripe mosaic virus-induced gene silencing (BSMV-IGS) as a tool for functional analysis of barley genes potentially involved in nonhost resistance.
[21586898] Plant Signal Behav 6(6): 867-9 (2011)
2011  
210
Alternate approaches to repress endogenous microRNA activity in Arabidopsis thaliana.
[21358288] Plant Signal Behav 6(3): 349-59 (2011)
2004  
211
Promoter bashing, microRNAs, and Knox genes. New insights, regulators, and targets-of-regulation in the establishment of lateral organ polarity in Arabidopsis.
[15208415] Plant Physiol 135(2): 685-94 (2004)
2008  
212
RNA silencing in plants: yesterday, today, and tomorrow.
[18524877] Plant Physiol 147(2): 456-68 (2008)
2009  
213
Contrast in aberrant microRNA expression in systemic lupus erythematosus and rheumatoid arthritis: is microRNA-146 all we need?
[19333929] Arthritis Rheum 60(4): 912-5 (2009)
2004  
214
2010  
215
Structural insights into RNA interference.
[20053548] Curr Opin Struct Biol 20(1): 90-7 (2010)
2009  
216
Structural and functional modules in RNA interference.
[19477631] Curr Opin Struct Biol 19(3): 286-93 (2009)
2008  
217
RISC-target interaction: cleavage and translational suppression.
[18692607] Biochim Biophys Acta 1779(11): 668-77 (2008)
2008  
218
Technical variables in high-throughput miRNA expression profiling: much work remains to be done.
[18439437] Biochim Biophys Acta 1779(11): 758-65 (2008)
2008  
219
Regulation of mammalian microRNA processing and function by cellular signaling and subcellular localization.
[18433727] Biochim Biophys Acta 1779(11): 678-81 (2008)
2008  
220
Interspecies regulation of microRNAs and their targets.
[18407843] Biochim Biophys Acta 1779(11): 735-42 (2008)
2008  
221
MicroRNA-206: the skeletal muscle-specific myomiR.
[18381085] Biochim Biophys Acta 1779(11): 682-91 (2008)
2008  
222
The roles of microRNAs in mammalian virus infection.
[18549828] Biochim Biophys Acta 1779(11): 706-11 (2008)
2006  
223
MicroRNA control of lifespan and metabolism.
[16627994] Cell Cycle 5(8): 837-40 (2006)
2006  
224
Delivery of RNA interference.
[16940756] Cell Cycle 5(18): 2103-9 (2006)
2006  
225
MicroRNAs: a new insight into cancer genome.
[17012848] Cell Cycle 5(19): 2216-9 (2006)
2006  
226
Epigenetic activation of tumor suppressor microRNAs in human cancer cells.
[17012846] Cell Cycle 5(19): 2220-2 (2006)
2010  
227
Regulation of Myc by miR-34c: A mechanism to prevent genomic instability?
[20603603] Cell Cycle 9(14): 2726-30 (2010)
2010  
228
Genome-wide RNAi screen discovers functional coupling of alternative splicing and cell cycle control to apoptosis regulation.
[21088477] Cell Cycle 9(22): 4419-21 (2010)
2010  
229
microRNA-34a is tumor suppressive in brain tumors and glioma stem cells.
[20190569] Cell Cycle 9(6): 1031-6 (2010)
2010  
230
MicroRNA-210: a unique and pleiotropic hypoxamir.
[20237418] Cell Cycle 9(6): 1072-83 (2010)
2008  
231
microRNAs and cancer: an overview.
[18719380] Cell Cycle 7(16): 2485-92 (2008)
2010  
232
Efficient siRNA delivery by novel PTD-DRBD fusion proteins.
[20090414] Cell Cycle 9(3): 424-5 (2010)
2007  
233
MicroRNA with a MacroFunction.
[17660716] Cell Cycle 6(15): 1850-5 (2007)
2009  
234
Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression.
[19221491] Cell Cycle 8(6): 843-52 (2009)
2009  
235
Systemic siRNA delivery to leukocyte-implicated diseases.
[19221492] Cell Cycle 8(6): 853-9 (2009)
2011  
236
microRNAs: fad or future of liver disease.
[21633658] World J Gastroenterol 17(20): 2536-42 (2011)
2007  
237
Transgenic RNA interference in mice.
[17557936] Physiology (Bethesda) 22(-): 161-6 (2007)
2010  
238
siRNA therapy for glomerulonephritis.
[20299356] J Am Soc Nephrol 21(4): 549-51 (2010)
2004  
239
2005  
240
New function of calreticulin: calreticulin-dependent mRNA destabilization.
[16284187] Circ Res 97(10): 961-3 (2005)
2006  
241
2006  
242
RNA-mediated gene silencing in hematopoietic cells.
[17057372] J Biomed Biotechnol 2006(4): 87340 (2006)
2006  
243
siRNA efficiency: structure or sequence-that is the question.
[17057371] J Biomed Biotechnol 2006(4): 83757 (2006)
2006  
244
Delivery systems for the direct application of siRNAs to induce RNA interference (RNAi) in vivo.
[17057369] J Biomed Biotechnol 2006(4): 71659 (2006)
2006  
245
MicroRNAs in gene regulation: when the smallest governs it all.
[17057368] J Biomed Biotechnol 2006(4): 69616 (2006)
2006  
246
Generation of RNAi libraries for high-throughput screens.
[17057364] J Biomed Biotechnol 2006(4): 45716 (2006)
2006  
247
The potential regulation of L1 mobility by RNA interference.
[16877813] J Biomed Biotechnol 2006(1): 32713 (2006)
2006  
248
Do small RNAs interfere with LINE-1?
[16877812] J Biomed Biotechnol 2006(1): 29049 (2006)
2010  
249
RNAi-based strategies for cyclooxygenase-2 inhibition in cancer.
[20625420] J Biomed Biotechnol 2010(-): 828045 (2010)
2010  
250
The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy.
[19617224] Cardiovasc Res 85(2): 330-8 (2010)
2010  
251
Cardiac-targeted delivery of regulatory RNA molecules and genes for the treatment of heart failure.
[20176815] Cardiovasc Res 86(3): 353-64 (2010)
2010  
252
MicroRNAs as regulators of death receptors signaling.
[19644509] Cell Death Differ 17(2): 200-8 (2010)
2010  
253
2010  
254
The miR-34 family in cancer and apoptosis.
[19461653] Cell Death Differ 17(2): 193-9 (2010)
2010  
255
miR-10 in development and cancer.
[19461655] Cell Death Differ 17(2): 209-14 (2010)
2010  
256
miR-15a and miR-16-1 in cancer: discovery, function and future perspectives.
[19498445] Cell Death Differ 17(2): 215-20 (2010)
2010  
257
MicroRNA-mediated control in the skin.
[19609273] Cell Death Differ 17(2): 229-35 (2010)
2008  
258
A microRNA component of the hypoxic response.
[18219318] Cell Death Differ 15(4): 667-71 (2008)
2010  
259
2011  
260
MicroRNAs and their roles in mammalian stem cells.
[21576351] J Cell Sci 124(Pt 11): 1775-83 (2011)
2009  
261
microRNAs and muscle disorders.
[19092056] J Cell Sci 122(Pt 1): 13-20 (2009)
2010  
262
miR-126 and miR-126*: new players in cancer.
[20953557] ScientificWorldJournal 10(-): 2090-100 (2010)
2010  
263
microRNAs in heart disease: putative novel therapeutic targets?
[20118173] Eur Heart J 31(6): 649-58 (2010)
2010  
264
MicroRNAs in skeletal muscle: their role and regulation in development, disease and function.
[20724363] J Physiol 588(Pt 21): 4075-87 (2010)
2010  
265
MicroRNAs and their therapeutic potential for human diseases: microRNAs, miR-143 and -145, function as anti-oncomirs and the application of chemically modified miR-143 as an anti-cancer drug.
[20953119] J Pharmacol Sci 114(3): 276-80 (2010)
2010  
266
MicroRNAs and their therapeutic potential for human diseases: aberrant microRNA expression in Alzheimer's disease brains.
[20953120] J Pharmacol Sci 114(3): 269-75 (2010)
2010  
267
MicroRNAs and their therapeutic potential for human diseases: MiR-133a and bronchial smooth muscle hyperresponsiveness in asthma.
[20953121] J Pharmacol Sci 114(3): 264-8 (2010)
2006  
268
MicroRNA: biogenetic and functional mechanisms and involvements in cell differentiation and cancer.
[16921236] J Pharmacol Sci 101(4): 267-70 (2006)
2011  
269
Non-coding RNAs and cancer: new paradigms in oncology.
[21447283] Discov Med 11(58): 245-54 (2011)
2011  
270
Optimizing siRNA delivery to the genital mucosa.
[21356167] Discov Med 11(57): 124-32 (2011)
2011  
271
MicroRNAs in chromosomal translocation-associated solid tumors: learning from sarcomas.
[22031668] Discov Med 12(65): 307-17 (2011)
2010  
272
Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.
[21034670] Discov Med 10(53): 293-304 (2010)
2010  
273
The therapeutic potential of microRNA modulation.
[20423675] Discov Med 9(47): 311-8 (2010)
2009  
274
The road to therapeutic RNA interference (RNAi): Tackling the 800 pound siRNA delivery gorilla.
[20040280] Discov Med 8(43): 253-6 (2009)
2009  
275
Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA.
[19366348] Br J Pharmacol 157(2): 179-94 (2009)
2011  
276
The role of the precursor structure in the biogenesis of microRNA.
[21607569] Cell Mol Life Sci 68(17): 2859-71 (2011)
2010  
277
Targeting viral infection by microRNA inhibition.
[20122293] Genome Biol 11(1): 201 (2010)
2008  
278
Bacterial pathogens encode suppressors of RNA-mediated silencing.
[18947381] Genome Biol 9(10): 237 (2008)
2011  
279
Hsa-miR-196a2 Rs11614913 polymorphism contributes to cancer susceptibility: evidence from 15 case-control studies.
[21483822] PLoS One 6(3): e18108 (2011)
2011  
280
Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: a meta-analysis.
[21637771] PLoS One 6(5): e20471 (2011)
2010  
281
A view from Drosophila: multiple biological functions for individual microRNAs.
[20211749] Semin Cell Dev Biol 21(7): 745-53 (2010)
2010  
282
MicroRNAs in mouse development and disease.
[20152923] Semin Cell Dev Biol 21(7): 774-80 (2010)
2010  
283
MicroRNAs as genetic sculptors: fishing for clues.
[20152922] Semin Cell Dev Biol 21(7): 760-7 (2010)
2010  
284
Computational methods to identify miRNA targets.
[20079866] Semin Cell Dev Biol 21(7): 738-44 (2010)
2010  
285
Expression of microRNAs and its regulation in plants.
[20403450] Semin Cell Dev Biol 21(8): 790-7 (2010)
2009  
286
Plant responses against invasive nucleic acids: RNA silencing and its suppression by plant viral pathogens.
[19524057] Semin Cell Dev Biol 20(9): 1032-40 (2009)
2010  
287
The ZEB/miR-200 feedback loop--a motor of cellular plasticity in development and cancer?
[20706219] EMBO Rep 11(9): 670-7 (2010)
2010  
288
The role of miRNAs and endogenous siRNAs in maternal-to-zygotic reprogramming and the establishment of pluripotency.
[20651740] EMBO Rep 11(8): 590-7 (2010)
2006  
289
A brief history of RNAi: the silence of the genes.
[16816104] FASEB J 20(9): 1293-9 (2006)
2010  
290
MicroRNAs in immune regulation--opportunities for cancer immunotherapy.
[20144731] Int J Biochem Cell Biol 42(8): 1256-61 (2010)
2009  
291
Reversal of HIV-1 latency with anti-microRNA inhibitors.
[18761423] Int J Biochem Cell Biol 41(3): 451-4 (2009)
2007  
292
Argonautes confront new small RNAs.
[17928262] Curr Opin Chem Biol 11(5): 569-77 (2007)
2007  
293
Toward reprogramming bacteria with small molecules and RNA.
[17967431] Curr Opin Chem Biol 11(6): 612-9 (2007)
2009  
294
AngiomiRs--key regulators of angiogenesis.
[19446450] Curr Opin Genet Dev 19(3): 205-11 (2009)
2008  
295
siRNA and miRNA processing: new functions for Cajal bodies.
[18337083] Curr Opin Genet Dev 18(2): 197-203 (2008)
2010  
296
MicroRNAs of the immune system: roles in inflammation and cancer.
[20146715] Ann N Y Acad Sci 1183(-): 183-94 (2010)
2006  
297
Therapeutic potential of RNAi in metabolic diseases.
[16629385] Biotechniques Suppl(-): 31-6 (2006)
2006  
298
RNAi as a treatment for HIV-1 infection.
[16629384] Biotechniques Suppl(-): 25-9 (2006)
2006  
299
RNA interference: a potential therapeutic tool for silencing splice isoforms linked to human diseases.
[16629383] Biotechniques Suppl(-): 15-22 (2006)
2006  
300
Therapeutic potential of siRNA-mediated transcriptional gene silencing.
[16629382] Biotechniques Suppl(-): 7-13 (2006)
2008  
301
RNAi mechanisms and applications.
[18474035] Biotechniques 44(5): 613-6 (2008)
2005  
302
Mammalian RNAi: a practical guide.
[16116795] Biotechniques 39(2): 215-24 (2005)
2010  
303
Measuring circulating miRNAs: the new "PSA" for Breast Cancer?
[20584810] Oncologist 15(7): 656 (2010)
2010  
304
The promise of microRNA replacement therapy.
[20807816] Cancer Res 70(18): 7027-30 (2010)
2010  
305
MicroRNAs and metastasis: little RNAs go a long way.
[20663901] Cancer Res 70(16): 6401-6 (2010)
2007  
306
MicroRNA: Potential for Cancer Detection, Diagnosis, and Prognosis.
[17510380] Cancer Res 67(10): 4553-5 (2007)
2008  
307
Targeted delivery of small interfering RNA: approaching effective cancer therapies.
[18316585] Cancer Res 68(5): 1247-50 (2008)
2009  
308
Metastamir: the field of metastasis-regulatory microRNA is spreading.
[19773429] Cancer Res 69(19): 7495-8 (2009)
2010  
309
The ups and downs of miR-205: identifying the roles of miR-205 in mammary gland development and breast cancer.
[20436283] RNA Biol 7(3): 300-4 (2010)
2008  
310
The microRNA-argonaute complex: a platform for mRNA modulation.
[18698153] RNA Biol 5(3): 123-7 (2008)
2008  
311
The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis.
[19182522] RNA Biol 5(3): 115-9 (2008)
2009  
312
Translation regulation of mRNAs by the fragile X family of proteins through the microRNA pathway.
[19276651] RNA Biol 6(2): 175-8 (2009)
2009  
313
Assaying microRNA loss-of-function phenotypes in mammalian cells: emerging tools and their potential therapeutic utility.
[19901530] RNA Biol 6(5): 541-5 (2009)
2009  
314
How to control miRNA maturation?
[19875945] RNA Biol 6(5): 536-40 (2009)
2009  
315
(micro)Genomic medicine: microRNAs as therapeutics and biomarkers.
[19502816] RNA Biol 6(3): 324-8 (2009)
2009  
316
MicroRNAs: novel biomarkers for human cancer.
[19246618] Clin Chem 55(4): 623-31 (2009)
2009  
317
MicroRNAs as novel myocardial biomarkers.
[19696114] Clin Chem 55(11): 1897-9 (2009)
2004  
318
RNA interference and its current application in mammals.
[15265387] Chin Med J (Engl) 117(7): 1084-91 (2004)
2007  
319
MicroRNA gene expression in malignant lymphoproliferative disorders.
[17624268] Chin Med J (Engl) 120(11): 996-9 (2007)
2005  
320
RNA interference & inhibition of viruses.
[15802755] Indian J Med Res 121(3): 147-50 (2005)
2010  
321
The new role of microRNAs in cancer.
[20799864] Future Oncol 6(8): 1203-6 (2010)
2010  
322
MicroRNA regulation of neural stem cells and neurogenesis.
[21068294] J Neurosci 30(45): 14931-6 (2010)
2010  
323
MicroRNA-induced silencing of glioma progression.
[20237256] J Neurosci 30(11): 3868-9 (2010)
2003  
324
siRNAs: a new wave of RNA-based therapeutics.
[12654731] J Antimicrob Chemother 51(4): 753-6 (2003)
2009  
325
Expression profiling of microRNAs by deep sequencing.
[19332473] Brief Bioinform 10(5): 490-7 (2009)
2006  
326
Integrated siRNA design based on surveying of features associated with high RNAi effectiveness.
[17129386] BMC Bioinformatics 7(-): 516 (2006)
2006  
327
Selecting effective siRNA sequences by using radial basis function network and decision tree learning.
[17254307] BMC Bioinformatics 7 Suppl 5(-): S22 (2006)
2008  
328
Finding microRNA regulatory modules in human genome using rule induction.
[19091028] BMC Bioinformatics 9 Suppl 12(): S5 (2008)
2007  
329
sIR: siRNA Information Resource, a web-based tool for siRNA sequence design and analysis and an open access siRNA database.
[17540034] BMC Bioinformatics 8(-): 178 (2007)
2008  
330
miRNAminer: a tool for homologous microRNA gene search.
[18215311] BMC Bioinformatics 9(-): 39 (2008)
2010  
331
Analysis of microRNA knockouts in mice.
[20805106] Hum Mol Genet 19(R2): R169-75 (2010)
2009  
332
RNAi nanoparticles in the service of personalized medicine.
[19958219] Nanomedicine (Lond) 4(8): 853-5 (2009)
2009  
333
Delivering the goods: realizing the clinical potential of RNAi.
[19663585] Nanomedicine (Lond) 4(6): 595-8 (2009)
2002  
334
Signaling in plants by intercellular RNA and protein movement.
[11799058] Genes Dev 16(2): 151-8 (2002)
2011  
335
Experimental strategies for microRNA target identification.
[21652644] Nucleic Acids Res 39(16): 6845-53 (2011)
2004  
336
siDirect: highly effective, target-specific siRNA design software for mammalian RNA interference.
[15215364] Nucleic Acids Res 32(Web Server issue): W124-9 (2004)
2010  
337
Sequence-non-specific effects of RNA interference triggers and microRNA regulators.
[19843612] Nucleic Acids Res 38(1): 1-16 (2010)
2008  
338
Endogenous small interfering RNAs in animals.
[18719707] Nat Rev Mol Cell Biol 9(9): 673-8 (2008)
2008  
339
Protein interactions and complexes in human microRNA biogenesis and function.
[17981733] Front Biosci 13(-): 2537-47 (2008)
2009  
340
MicroRNA: a new frontier in kidney and blood pressure research.
[19339633] Am J Physiol Renal Physiol 297(3): F553-8 (2009)
2010  
341
CHI conference on microRNAs: dramatic expansion of research tools and discoveries.
[20629503] Expert Rev Mol Diagn 10(5): 555-7 (2010)
2011  
342
miRNAs: roles and clinical applications in vascular disease.
[21171923] Expert Rev Mol Diagn 11(1): 79-89 (2011)
2009  
343
2009  
344
Current molecular diagnostics of breast cancer and the potential incorporation of microRNA.
[19580430] Expert Rev Mol Diagn 9(5): 455-67 (2009)
2009  
345
Intensive RNAi with lentiviral vectors in mammalian cells.
[19041944] Methods 47(4): 298-303 (2009)
2007  
346
Part A - microRNAs: discovery, analyses, targets.
[17889794] Methods 43(2): 89-90 (2007)
2008  
347
Experimental validation of miRNA targets.
[18158132] Methods 44(1): 47-54 (2008)
2008  
348
Real-time PCR quantification of precursor and mature microRNA.
[18158130] Methods 44(1): 31-8 (2008)
2008  
349
Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing.
[18158127] Methods 44(1): 3-12 (2008)
2008  
350
Gene regulation by transcription factors and microRNAs.
[18369135] Science 319(5871): 1785-6 (2008)
2008  
351
Circular reasoning: microRNAs and cell-cycle control.
[18774719] Trends Biochem Sci 33(10): 474-81 (2008)
2010  
352
Nuclear networking fashions pre-messenger RNA and primary microRNA transcripts for function.
[20004579] Trends Cell Biol 20(1): 52-61 (2010)
2010  
353
Cross-talk between miRNA and Notch signaling pathways in tumor development and progression.
[20022691] Cancer Lett 292(2): 141-8 (2010)
2009  
354
Control of microRNA biogenesis by TGFbeta signaling pathway-A novel role of Smads in the nucleus.
[19892582] Cytokine Growth Factor Rev 20(5-6): 517-21 (2009)
2011  
355
Role of microRNAs in endothelial cell pathophysiology.
[21946298] Pol Arch Med Wewn 121(10): 361-6 (2011)
2007  
356
MicroRNAs and genomic instability.
[17113784] Semin Cancer Biol 17(1): 65-73 (2007)
2010  
357
In vivo imaging of RNA interference.
[20080892] J Nucl Med 51(2): 169-72 (2010)
2010  
358
MicroRNAs in psychiatric and neurodevelopmental disorders.
[20388499] Brain Res 1338(-): 78-88 (2010)
2010  
359
MicroRNAs in neural cell differentiation.
[20382133] Brain Res 1338(-): 14-9 (2010)
2010  
360
MicroRNAs and deregulated gene expression networks in neurodegeneration.
[20380815] Brain Res 1338(-): 48-57 (2010)
2010  
361
High-throughput experimental studies to identify miRNA targets directly, with special focus on the mammalian brain.
[20380813] Brain Res 1338(-): 122-30 (2010)
2010  
362
MicroRNAs as a molecular basis for mental retardation, Alzheimer's and prion diseases.
[20347722] Brain Res 1338(-): 58-66 (2010)
2010  
363
MicroRNA dysregulation in psychiatric disease.
[20303342] Brain Res 1338(-): 89-99 (2010)
2010  
364
MicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotype.
[19843580] Endocr Relat Cancer 17(1): F51-75 (2010)
2010  
365
MicroRNAs: a great challenge for the diagnosis and therapy of endocrine cancers.
[20118497] Endocr Relat Cancer 17(1): E3-4 (2010)
2010  
366
2010  
367
The role of let-7 in cell differentiation and cancer.
[19779035] Endocr Relat Cancer 17(1): F19-36 (2010)
2010  
368
Apoptomirs: small molecules have gained the license to kill.
[19815577] Endocr Relat Cancer 17(1): F37-50 (2010)
2010  
369
Selective gene silencing by viral delivery of short hairpin RNA.
[20858246] Virol J 7(-): 248 (2010)
2011  
370
siRNAs: potential therapeutic agents against hepatitis C virus.
[21645341] Virol J 8(-): 276 (2011)
2011  
371
Small RNAs in early mammalian development: from gametes to gastrulation.
[21486922] Development 138(9): 1653-61 (2011)
2006  
372
MicroRNA biogenesis, functionality and cancer relevance.
[17426780] Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 150(2): 205-15 (2006)
2008  
373
Interplay between microRNAs and RNA-binding proteins determines developmental processes.
[18414021] Cell Cycle 7(7): 899-903 (2008)
2009  
374
MicroRNAs: key modulators of posttranscriptional gene expression.
[19049808] Gastroenterology 136(1): 17-25 (2009)
2011  
375
Vertebrate virus-encoded microRNAs and their sequence conservation.
[21937815] Jpn J Infect Dis 64(5): 357-66 (2011)
2011  
376
Synthetic RNA silencing in bacteria - antimicrobial discovery and resistance breaking.
[21941522] Front Microbiol 2(-): 185 (2011)
2011  
377
Francisella Subverts Innate Immune Signaling: Focus On PI3K/Akt.
[21686123] Front Microbiol 5(-): 13 (2011)
2010  
378
Mammalian MicroRNAs: Post-Transcriptional Gene Regulation in RNA Virus Infection and Therapeutic Applications.
[21607080] Front Microbiol 1(-): 108 (2010)
2010  
379
The clinical potential of microRNAs.
[20925959] J Hematol Oncol 3(-): 37 (2010)
2010  
380
Genetic variation in microRNA networks: the implications for cancer research.
[20495573] Nat Rev Cancer 10(6): 389-402 (2010)
2011  
381
RNA interference in the clinic: challenges and future directions.
[21160526] Nat Rev Cancer 11(1): 59-67 (2011)
2007  
382
Targeted delivery systems of small interfering RNA by systemic administration.
[17603214] Drug Metab Pharmacokinet 22(3): 142-51 (2007)
2010  
383
Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research.
[20306121] Pharm Res 27(6): 1027-41 (2010)
2008  
384
RNAi for treating hepatitis B viral infection.
[18074201] Pharm Res 25(1): 72-86 (2008)
2009  
385
MicroRNA involvement in the pathogenesis of neuroblastoma: potential for microRNA mediated therapeutics.
[19199973] Curr Pharm Des 15(4): 456-62 (2009)
2011  
386
Principles of microRNA involvement in human cancers.
[22035854] Chin J Cancer 30(11): 739-48 (2011)
2011  
387
The expression and functions of microRNAs in pancreatic adenocarcinoma and hepatocellular carcinoma.
[21801602] Chin J Cancer 30(8): 540-50 (2011)
2011  
388
MicroRNA therapeutics: principles, expectations, and challenges.
[21627858] Chin J Cancer 30(6): 368-70 (2011)
2011  
389
Single-nucleotide polymorphisms among microRNA: big effects on cancer.
[21627860] Chin J Cancer 30(6): 381-91 (2011)
2011  
390
Measurable evidence of miRNAs as regulators of cancer networks and therapeutic targets.
[21381902] Expert Rev Med Devices 8(2): 123-6 (2011)
2007  
391
Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model.
[17941951] Br J Haematol 139(5): 645-57 (2007)
2010  
392
MicroRNAs in leukemias: emerging diagnostic tools and therapeutic targets.
[20370647] Curr Drug Targets 11(7): 801-11 (2010)
2011  
393
MicroRNAs in β-cell biology, insulin resistance, diabetes and its complications.
[21709277] Diabetes 60(7): 1825-31 (2011)
2011  
394
Diabetes complications: the microRNA perspective.
[21709278] Diabetes 60(7): 1832-7 (2011)
2008  
395
Renal response to metabolic acidosis: role of mRNA stabilization.
[17914349] Kidney Int 73(1): 11-8 (2008)
2010  
396
MicroRNAs in inflammatory lung disease--master regulators or target practice?
[21029443] Respir Res 11(-): 148 (2010)
2010  
397
microRNAs: a newly described class of encoded molecules that play a role in health and disease.
[21311629] Hippokratia 14(4): 236-40 (2010)
2011  
398
Circulating microRNAs: possible prediction biomarkers for personalized therapy of non-small-cell lung carcinoma.
[21273174] Clin Lung Cancer 12(1): 14-7 (2011)
2009  
399
Circulating MicroRNA Signatures of Tumor-Derived Exosomes for Early Diagnosis of Non-Small-Cell Lung Cancer.
[19289365] Clin Lung Cancer 10(1): 8-9 (2009)
2011  
400
MicroRNAs, an active and versatile group in cancers.
[22010574] Int J Oral Sci 3(4): 165-75 (2011)
2011  
401
MicroRNA Dysregulation in Colon Cancer Microenvironment Interactions: The Importance of Small Things in Metastases.
[21909877] Cancer Microenviron 4(2): 155-62 (2011)
2010  
402
The Roles of MicroRNAs in the Cancer Invasion-Metastasis Cascade.
[21209780] Cancer Microenviron 3(1): 137-47 (2010)
2008  
403
Viruses and RNA silencing.
[19122390] Uirusu 58(1): 61-8 (2008)
2008  
404
Transposable elements, RNA silencing, and their impacts on the genome throughout evolution.
[19122389] Uirusu 58(1): 55-60 (2008)
2010  
405
MicroRNAs: small RNAs with big effects.
[20574417] Transplantation 90(2): 105-12 (2010)
2009  
406
MicroRNAs: control and loss of control in human physiology and disease.
[19030926] World J Surg 33(4): 667-84 (2009)
2009  
407
Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis.
[19030927] World J Surg 33(4): 698-709 (2009)
2010  
408
MicroRNAs as biomarkers in rheumatic diseases.
[20517293] Nat Rev Rheumatol 6(7): 391-8 (2010)
2010  
409
miRNA control of tumor cell invasion and metastasis.
[19877123] Int J Cancer 126(6): 1283-90 (2010)
2007  
410
Investigation of miRNA biology by bioinformatic tools and impact of miRNAs in colorectal cancer--regulatory relationship of c-Myc and p53 with miRNAs.
[18079974] Cancer Inform 3(-): 245-53 (2007)
2011  
411
Variables and strategies in development of therapeutic post-transcriptional gene silencing agents.
[21785698] J Ophthalmol 2011(-): 531380 (2011)
2006  
412
On the origin and functions of RNA-mediated silencing: from protists to man.
[16691418] Curr Genet 50(2): 81-99 (2006)
2008  
413
Identification and function of human cytomegalovirus microRNAs.
[18243786] J Clin Virol 41(3): 186-91 (2008)
2010  
414
Context-dependent functions of specific microRNAs in neuronal development.
[20920300] Neural Dev 5(-): 25 (2010)
2011  
415
Structural diversity repertoire of gene silencing small interfering RNAs.
[21749289] Nucleic Acid Ther 21(3): 125-31 (2011)
2010  
416
RNA interference in schistosomes: machinery and methodology.
[19765345] Parasitology 137(3): 485-95 (2010)
2010  
417
Profiling of regulatory microRNA transcriptomes in various biological processes: a review.
[21063068] J Appl Genet 51(4): 501-7 (2010)
2008  
418
Origins and evolution of eukaryotic RNA interference.
[18715673] Trends Ecol Evol 23(10): 578-87 (2008)
2009  
419
Regulation of non-coding RNA networks in the nervous system--what's the REST of the story?
[19679163] Neurosci Lett 466(2): 73-80 (2009)
2008  
420
MicroRNAs (miRNAs) in neurodegenerative diseases.
[18226108] Brain Pathol 18(1): 130-8 (2008)
2010  
421
A status report on RNAi therapeutics.
[20615220] Silence 1(1): 14 (2010)
2011  
422
Posttranslational modification of Argonautes and their role in small RNA-mediated gene regulation.
[21943311] Silence 2(-): 5 (2011)
2010  
423
CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea.
[20125085] Nat Rev Genet 11(3): 181-90 (2010)
2008  
424
Biological principles of microRNA-mediated regulation: shared themes amid diversity.
[18852696] Nat Rev Genet 9(11): 831-42 (2008)
2008  
425
MicroRNAs in the Hox network: an apparent link to posterior prevalence.
[18781158] Nat Rev Genet 9(10): 789-96 (2008)
2011  
426
Small RNA biology is systems biology.
[21266101] BMB Rep 44(1): 11-21 (2011)
2010  
427
The role of micro-ribonucleic acids in normal hematopoiesis and leukemic T-lymphogenesis.
[20549139] Braz J Med Biol Res 43(7): 619-26 (2010)
2006  
428
2007  
429
RNA interference based gene therapy for neurological disease.
[17478451] Brief Funct Genomic Proteomic 6(1): 40-9 (2007)
2008  
430
Studying gene function in Caenorhabditis elegans using RNA-mediated interference.
[18443013] Brief Funct Genomic Proteomic 7(3): 184-94 (2008)
2010  
431
Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseases.
[20815877] Mol Cancer 9(-): 232 (2010)
2010  
432
MicroRNA roles in beta-catenin pathway.
[20858269] Mol Cancer 9(-): 252 (2010)
2010  
433
Microprocessor of microRNAs: regulation and potential for therapeutic intervention.
[20515486] Mol Cancer 9(-): 134 (2010)
2011  
434
MicroRNAs in rhabdomyosarcoma: pathogenetic implications and translational potentiality.
[21943149] Mol Cancer 10(-): 120 (2011)
2010  
435
Serum microRNAs as non-invasive biomarkers for cancer.
[21110877] Mol Cancer 9(-): 306 (2010)
2011  
436
Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer.
[21767219] Clin Chem Lab Med 49(10): 1591-603 (2011)
2010  
437
Small RNA diversity in plants and its impact in development.
[20808519] Curr Genomics 11(1): 14-23 (2010)
2010  
438
Pooled RNAi Screens - Technical and Biological Aspects.
[21037854] Curr Genomics 11(3): 162-7 (2010)
2011  
439
MicroRNA functional network in pancreatic cancer: from biology to biomarkers of disease.
[21799259] J Biosci 36(3): 481-91 (2011)
2011  
440
Pervasive roles of microRNAs in cardiovascular biology.
[21248840] Nature 469(7330): 336-42 (2011)
2007  
441
Transcription and RNA interference in the formation of heterochromatin.
[17522672] Nature 447(7143): 399-406 (2007)
2010  
442
Novel RNA-based strategies for therapeutic gene silencing.
[20087319] Mol Ther 18(3): 466-76 (2010)
2009  
443
MicroRNAs and the regulation of vector tropism.
[19107117] Mol Ther 17(3): 409-16 (2009)
2010  
444
MicroRNAs in diagnosis and prognosis in cancer: what does the future hold?
[20415558] Pharmacogenomics 11(5): 667-9 (2010)
2010  
445
2005  
446
RNAi specificity: how big of an issue is it?
[15723598] Pharmacogenomics 6(1): 1-4 (2005)
2009  
447
MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine.
[19290790] Pharmacogenomics 10(3): 399-416 (2009)
2009  
448
Novel less-abundant viral microRNAs encoded by herpes simplex virus 2 latency-associated transcript and their roles in regulating ICP34.5 and ICP0 mRNAs.
[19019961] J Virol 83(3): 1433-42 (2009)
2011  
449
Tumor suppressor p53 meets microRNAs.
[21278451] J Mol Cell Biol 3(1): 44-50 (2011)
2011  
450
MicroRNAs in NF-kappaB signaling.
[21502305] J Mol Cell Biol 3(3): 159-66 (2011)
2011  
451
The emerging roles of microRNAs in the molecular responses of metabolic rate depression.
[21177365] J Mol Cell Biol 3(3): 167-75 (2011)
2011  
452
MicroRNAs: new players in the DNA damage response.
[21183529] J Mol Cell Biol 3(3): 151-8 (2011)
2010  
453
Novel endoribonucleases as central players in various pathways of eukaryotic RNA metabolism.
[20675404] RNA 16(9): 1692-724 (2010)
2010  
454
MicroRNA sponges: progress and possibilities.
[20855538] RNA 16(11): 2043-50 (2010)
2010  
455
MicroRNAs, macrocontrol: regulation of miRNA processing.
[20423980] RNA 16(6): 1087-95 (2010)
2004  
456
"siRNAs and miRNAs": a meeting report on RNA silencing.
[15272116] RNA 10(8): 1165-73 (2004)
2007  
457
RNA stem-loops: to be or not to be cleaved by RNAse III.
[17299129] RNA 13(4): 457-62 (2007)
2009  
458
Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell.
[19561119] RNA 15(8): 1443-61 (2009)
2010  
459
Consensus miRNA expression profiles derived from interplatform normalization of microarray data.
[19948767] RNA 16(1): 16-25 (2010)
2010  
460
Roles of small RNAs in tumor formation.
[20493775] Trends Mol Med 16(6): 257-67 (2010)
2010  
461
Five questions about viruses and microRNAs.
[20195463] PLoS Pathog 6(2): e1000787 (2010)
2007  
462
Antiviral immunity directed by small RNAs.
[17693253] Cell 130(3): 413-26 (2007)
2009  
463
Origins and Mechanisms of miRNAs and siRNAs.
[19239886] Cell 136(4): 642-55 (2009)
2008  
464
miRiad roles for the miR-17-92 cluster in development and disease.
[18423194] Cell 133(2): 217-22 (2008)
2010  
465
MicroRNA: A matter of life or death.
[21537368] World J Biol Chem 1(4): 41-54 (2010)
2010  
466
MHC class II regulation by epigenetic agents and microRNAs.
[19771399] Immunol Res 46(1-3): 45-58 (2010)
2011  
467
Practical Aspects of microRNA Target Prediction.
[21342132] Curr Mol Med 11(2): 93-109 (2011)
2007  
468
Regulatory RNAs: future perspectives in diagnosis, prognosis, and individualized therapy.
[17172720] Methods Mol Biol 361(-): 311-26 (2007)
2008  
469
The role of microRNAs (miRNA) in circadian rhythmicity.
[19147939] J Genet 87(5): 505-11 (2008)
2010  
470
MicroRNA functions in stress responses.
[20965416] Mol Cell 40(2): 205-15 (2010)
2007  
471
Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways.
[17521938] Mol Genet Metab 91(3): 209-17 (2007)
2009  
472
Concepts in in vivo siRNA delivery for cancer therapy.
[19391103] J Cell Physiol 220(2): 285-91 (2009)
2007  
473
Modulating the expression of disease genes with RNA-based therapy.
[17604456] PLoS Genet 3(6): e109 (2007)
2008  
474
Advances in microRNAs: implications for gene therapists.
[18092919] Hum Gene Ther 19(1): 27-38 (2008)
2008  
475
Expression strategies for short hairpin RNA interference triggers.
[18363506] Hum Gene Ther 19(4): 313-7 (2008)
2010  
476
The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases.
[20678503] J Mol Biol 402(3): 491-509 (2010)
2010  
477
Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
[20413677] J Mol Diagn 12(4): 433-40 (2010)
2006  
478
Virus counterdefense: diverse strategies for evading the RNA-silencing immunity.
[16768647] Annu Rev Microbiol 60(-): 503-31 (2006)
2011  
479
The roles of microRNAs in tumorigenesis and angiogenesis.
[21760972] Int J Physiol Pathophysiol Pharmacol 3(2): 140-55 (2011)
2008  
480
Viral and cellular microRNAs as determinants of viral pathogenesis and immunity.
[18541214] Cell Host Microbe 3(6): 375-87 (2008)
2011  
481
MicroRNAs: their discovery, biogenesis, function and potential use as biomarkers in non-invasive prenatal diagnostics.
[21915364] Int J Mol Epidemiol Genet 2(3): 253-60 (2011)
2009  
482
RNAi screening: tips and techniques.
[19621037] Nat Immunol 10(8): 799-804 (2009)
2009  
483
Statistical methods for analysis of high-throughput RNA interference screens.
[19644458] Nat Methods 6(8): 569-75 (2009)
2011  
484
Regulation of microRNA expression and function by nuclear receptor signaling.
[21936947] Cell Biosci 1(1): 31 (2011)
2010  
485
Emergence of chemical biology approaches to the RNAi/miRNA pathway.
[20609408] Chem Biol 17(6): 584-9 (2010)
2010  
486
Emerging roles of microRNAs in the control of embryonic stem cells and the generation of induced pluripotent stem cells.
[20478297] Dev Biol 344(1): 16-25 (2010)
2011  
487
MicroRNAs in Human Diseases: From Cancer to Cardiovascular Disease.
[21860607] Immune Netw 11(3): 135-54 (2011)
2011  
488
A Potential of microRNAs for High-Content Screening.
[21922044] J Nucleic Acids 2011(-): 870903 (2011)
2009  
489
Role of specific microRNAs for endothelial function and angiogenesis.
[19540203] Biochem Biophys Res Commun 386(4): 549-53 (2009)
2009  
490
MicroRNAs in cardiovascular biology and heart disease.
[20031613] Circ Cardiovasc Genet 2(4): 402-8 (2009)
2009  
491
MicroRNA in autoimmunity and autoimmune diseases.
[19303254] J Autoimmun 32(3-4): 189-94 (2009)
2010  
492
Mechanisms of control of microRNA biogenesis.
[20833630] J Biochem 148(4): 381-92 (2010)
2010  
493
Robust and specific inhibition of microRNAs in Caenorhabditis elegans.
[20359318] J Biol 9(3): 20 (2010)
2008  
494
MicroRNAs and cancer: past, present, and potential future.
[19074842] Mol Cancer Ther 7(12): 3655-60 (2008)
2009  
495
RNA-directed transcriptional gene silencing and activation in human cells.
[19943804] Oligonucleotides 19(4): 299-306 (2009)
2011  
496
RITS-connecting transcription, RNA interference, and heterochromatin assembly in fission yeast.
[21823226] Wiley Interdiscip Rev RNA 2(5): 632-46 (2011)
2011  
497
Vigilance and validation: Keys to success in RNAi screening.
[21142076] ACS Chem Biol 6(1): 47-60 (2011)
2011  
498
Transcript profiling and RNA interference as tools to identify small molecule mechanisms and therapeutic potential.
[21105689] ACS Chem Biol 6(1): 21-33 (2011)
2010  
499
The emerging role of microRNAs in drug responses.
[21154161] Curr Opin Mol Ther 12(6): 695-702 (2010)
2010  
500
Designing highly active siRNAs for therapeutic applications.
[21078115] FEBS J 277(23): 4806-13 (2010)
2010  
501
MicroRNAs: redefining mechanisms in cardiac disease.
[21282985] J Cardiovasc Pharmacol 56(6): 589-95 (2010)
2010  
502
Application of RNA interference in treating human diseases.
[21273705] J Genet 89(4): 527-37 (2010)
2011  
503
Genome-wide approaches in the study of microRNA biology.
[21197653] Wiley Interdiscip Rev Syst Biol Med 3(5): 491-512 (2011)
2010  
504
Staying on message: design principles for controlling nonspecific responses to siRNA.
[21078117] FEBS J 277(23): 4828-36 (2010)
2010  
505
Efficient and targeted delivery of siRNA in vivo.
[21078116] FEBS J 277(23): 4814-27 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\RNA (MicroRNA).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\RNA (MicroRNA).php on line 92